@article{375159097027418c985df1a88fecf3ba,
title = "The sickle cell disease implementation consortium: Translating evidence-based guidelines into practice for sickle cell disease",
author = "{for the Sickle Cell Disease Implementation Consortium} and DiMartino, {Lisa D.} and Baumann, {Ana A.} and Hsu, {Lewis L.} and Julie Kanter and Gordeuk, {Victor R.} and Jeffrey Glassberg and Treadwell, {Marsha J.} and Melvin, {Cathy L.} and Joseph Telfair and Klesges, {Lisa M.} and Allison King and Ted Wun and Nirmish Shah and Gibson, {Robert W} and Hankins, {Jane S.}",
note = "Funding Information: The SCD Implementation Consortium has been supported by US Federal Government cooperative agreements HL133948, HL133964, HL133990, HL133996, HL133994, HL133997, HL134004, HL134007, and HL134042 from the National Heart Lung and Blood Institute and the National Institute on Minority Health and Health Disparities (Bethesda, MD). Funding Information: JSH receives research funding support from Global Blood Therapeutics and Novartis and is a consultant for Bluebird Bio and National Committee for Quality Assurance; LLH is a consultant for Emmi Corp, Hilton Publishing, Pfizer, Global Blood Therapeutics, and AstraZeneca; JG receives research funding support from Pfizer; AK owns stock in Magenta Therapeutics; TW receives research funding support from Pfizer; NS receives speaker honoraria and research funding support from Novartis. All other authors declare no competing financial interests.",
year = "2018",
month = dec,
doi = "10.1002/ajh.25282",
language = "English (US)",
volume = "93",
pages = "E391--E395",
journal = "American Journal of Hematology",
issn = "0361-8609",
publisher = "Wiley-Liss Inc.",
number = "12",
}